Yunze Xu

机构：Chengdu University of Traditional Chinese Medicine · ORCID：0000-0001-9469-942X

发表论文 37 篇 · 总被引 671 次 · h-index 13

代表论文

• CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition (2019 · Cell Communication and Signaling · 被引 92)
• Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma (2022 · European Urology · 被引 57)
• Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma (2021 · OncoImmunology · 被引 55)
• High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma (2016 · PLoS ONE · 被引 45)
• Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression (2017 · Journal of Cancer Research and Clinical Oncology · 被引 29)
• Sphingosine kinase 1 overexpression contributes to sunitinib resistance in clear cell renal cell carcinoma (2018 · OncoImmunology · 被引 25)